MedTrace Logo

Glycemic Response in Persons With Type 2 Diabetes Mellitus

NCT04168541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-05-15

No results posted yet for this study

Summary

This will be a randomized crossover design. The subjects will be randomized to one of six interventions on six separate study days, one week apart.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Oral Nutrition Supplement

Product intake of oral nutrition supplement provided

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Joel Neutel, MD · Orange County Research Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2018-04-18
Completion
2018-04-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168541 on ClinicalTrials.gov